Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Intuitive Surgical, Inc. Revenue & Financial Statements
Intuitive Surgical, Inc. reported revenue of $10.1B for the fiscal year ended December 31, 2025, up 20.5% year over year, with net income of $2.9B and diluted EPS of $7.87.
- Company
- Intuitive Surgical, Inc. ISRG · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 5.7B | 6.2B | 7.1B | 8.4B | 10.1B |
| Cost of revenue | 1.8B | 2.0B | 2.4B | 2.7B | 3.4B |
| Gross profit | 4.0B | 4.2B | 4.7B | 5.6B | 6.6B |
| Operating income | 1.8B | 1.6B | 1.8B | 2.3B | 2.9B |
| Pretax income | 1.3B | 956.7M | 1.3B | 1.8B | 1.0B |
| Net income | 1.7B | 1.3B | 1.8B | 2.3B | 2.9B |
| Diluted EPS | 4.66 | 3.65 | 5.03 | 6.42 | 7.87 |
| EBITDA | 2.1B | 1.9B | 2.1B | 2.8B | 3.5B |
Quarterly
| USD | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0B | 2.0B | 2.4B | 2.3B | 2.4B | 2.5B | 2.9B | 2.8B |
| Cost of revenue | 637.2M | 664.2M | 771.3M | 795.7M | 822.1M | 842.7M | 961.9M | 940.3M |
| Gross profit | 1.4B | 1.4B | 1.6B | 1.5B | 1.6B | 1.7B | 1.9B | 1.8B |
| Operating income | 567.3M | 577.3M | 734.9M | 578.1M | 743.4M | 759.7M | 864.3M | 855.3M |
| Pretax income | 654.5M | 671.0M | 809.8M | 668.5M | 832.1M | 855.2M | 955.6M | 940.4M |
| Net income | 526.9M | 565.1M | 685.7M | 698.4M | 658.4M | 704.4M | 799.5M | 826.0M |
| Diluted EPS | 1.46 | 1.56 | 1.89 | 1.92 | 1.81 | 1.95 | 2.20 | 2.28 |
| EBITDA | — | — | — | — | — | — | — | — |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 13.6B | 13.0B | 15.4B | 18.7B | 20.5B |
| Current assets | 5.8B | 6.3B | 7.9B | 7.1B | 9.8B |
| Cash & equivalents | 1.3B | 1.6B | 2.8B | 2.0B | 3.4B |
| Total liabilities | 1.6B | 1.9B | 2.0B | 2.2B | 2.5B |
| Current liabilities | 1.1B | 1.4B | 1.7B | 1.7B | 2.0B |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | 11.9B | 11.0B | 13.3B | 16.4B | 17.8B |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 2.1B | 1.5B | 1.8B | 2.4B | 3.0B |
| Investing cash flow | (2.5B) | 1.4B | (360.1M) | (3.3B) | 665.8M |
| Financing cash flow | 43.0M | (2.6B) | (287.6M) | 150.9M | (2.4B) |
| Capital expenditure | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 449.2M | 513.2M | 592.8M | 676.8M | 788.2M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every ISRG filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.